Flaherty LE - Search Results

1

Adjuvant immunotherapy of resected, intermediate-thickness, node-negative melanoma with an allogeneic tumor vaccine: overall results of a randomized trial of the Southwest Oncology Group.

Sondak VK, Liu PY, Tuthill RJ, Kempf RA, Unger JM, Sosman JA, Thompson JA, Weiss GR, Redman BG, Jakowatz JG, Noyes RD, Flaherty LE. Sondak VK, et al. Among authors: flaherty le. J Clin Oncol. 2002 Apr 15;20(8):2058-66. doi: 10.1200/JCO.2002.08.071. J Clin Oncol. 2002. PMID: 11956266 Clinical Trial.

2

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.

Poplin EA, Corbett T, Flaherty L, Tarasoff P, Redman BG, Valdivieso M, Baker L. Poplin EA, et al. Invest New Drugs. 1992 Aug;10(3):165-70. doi: 10.1007/BF00877241. Invest New Drugs. 1992. PMID: 1428726 Clinical Trial.

3

Effect of calcium replacement on the hemodynamic changes associated with high dose interleukin-2 therapy.

Redman BG, Flaherty L, Martino S, Kraut M, Wisniewski C, Valdivieso M, Bander JJ. Redman BG, et al. Am J Clin Oncol. 1992 Aug;15(4):340-3. doi: 10.1097/00000421-199208000-00014. Am J Clin Oncol. 1992. PMID: 1514532 Clinical Trial.

4

Reversible cardiomyopathy after high-dose interleukin-2 therapy.

Goel M, Flaherty L, Lavine S, Redman BG. Goel M, et al. J Immunother (1991). 1992 Apr;11(3):225-9. doi: 10.1097/00002371-199204000-00010. J Immunother (1991). 1992. PMID: 1515427

5

Dacarbazine and outpatient interleukin-2 in treatment of metastatic malignant melanoma: phase II Southwest Oncology Group trial.

Flaherty LE, Liu PY, Fletcher WS, Goodwin JW, Balcerzak SP, Daniels D, Stephens RL, Sondak VK. Flaherty LE, et al. J Natl Cancer Inst. 1992 Jun 3;84(11):893-4. doi: 10.1093/jnci/84.11.893. J Natl Cancer Inst. 1992. PMID: 1593656 Clinical Trial. No abstract available.

6

Phase I trial of recombinant macrophage colony-stimulating factor by rapid intravenous infusion in patients with cancer.

Redman BG, Flaherty L, Chou TH, Kraut M, Martino S, Simon M, Valdivieso M, Groves E. Redman BG, et al. J Immunother (1991). 1992 Jul;12(1):50-4. doi: 10.1097/00002371-199207000-00006. J Immunother (1991). 1992. PMID: 1637782 Clinical Trial.

7

5-Fluorouracil, etoposide, and cisplatin in the management of metastatic non-small cell lung cancer.

Flaherty L, Wozniak A, Redman B, Kraut M, Martino S, Heilbrun L, Valdivieso M. Flaherty L, et al. Cancer. 1991 Sep 1;68(5):944-7. doi: 10.1002/1097-0142(19910901)68:5<944::aid-cncr2820680506>3.0.co;2-g. Cancer. 1991. PMID: 1655218 Clinical Trial.

8

SWOG 8825: melphalan GM-CSF: a phase I study.

Poplin E, Smith H, Behrens B, Redman B, Flaherty L, Neidhart J, Alberts D. Poplin E, et al. Gynecol Oncol. 1992 Jan;44(1):66-70. doi: 10.1016/0090-8258(92)90014-a. Gynecol Oncol. 1992. PMID: 1730428 Clinical Trial.

9

Sequential dacarbazine/cisplatin and interleukin-2 in metastatic melanoma: immunological effects of therapy.

Redman BG, Flaherty L, Chou TH, Nakeff A, Pillote K, Kaplan J. Redman BG, et al. J Immunother (1991). 1991 Apr;10(2):147-51. doi: 10.1097/00002371-199104000-00009. J Immunother (1991). 1991. PMID: 2043595

10

Phase II study of deoxydoxorubicin in previously untreated metastatic breast cancer.

Martino S, Samal BA, Redman B, Flaherty L, Kraut M, Simon M, Valdivieso M. Martino S, et al. Breast Cancer Res Treat. 1990 Dec;17(2):139-43. doi: 10.1007/BF01806294. Breast Cancer Res Treat. 1990. PMID: 2096991 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters